Oral Health in Children and Adolescents With Obesity and Normal Weight

February 22, 2024 updated by: Aslı Sogukpınar, Kahramanmaras Sutcu Imam University

Erosive Tooth Wear, Caries Experience and Periodontal Health in Children and Adolescents With Obesity and Normal Weight

We aimed to compare the oral health status (dmft/DMFT index, IDCAS-II, BEWE, plaque index, gingival index, probing depth) between normal-weight (NW) and obese (OW) children/adolescents.

82 participants aged 6-16 years were concluded in this cross-sectional study. The children/adolescents were classified according to the body mass index (BMI): NW (n=41) and OW (n=41). Caries experience was assessed by the International Caries Detection and Assessment System (ICDAS-II), decay, missing, filling teeth (dmft) for the primary teeth and (DMFT) for the permanent teeth, erosive tooth wear using Basic Erosive Wear Examination (BEWE), Plaque Index (PI) and Gingival Index (GI), Probing Depth (PD).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Also, the relationship between procalcitonin (PCT), C-reactive protein (CRP), parathormone (PTH), and 25(OH)D blood biochemistry and oral health was evaluated in obese children/adolescents.

Study Type

Interventional

Enrollment (Actual)

82

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Mersin, Turkey
        • Aslı Soğukpınar Önsüren

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria: 6-16 years obesity children and adolescents

  • 6-16 years healthy children and adolescents

Exclusion Criteria:

  • Infection,
  • diabetes, leukemia, asthma, bronchitis, cognitive neuromotor disorder, hormonal disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Kahramanmaraş Sütçü İmam University
Patient who apply to our clinic for routine paediatric treatment for the included in the study
Diagnostic test: oral health status
the dentists examined the dried teeth with a probe and mount mirror in a dental unit.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the results of DMFT, plaque and gingival indies
Time Frame: 12 months
The results of the study indicate that individuals with obesity tend to exhibit significantly higher scores for DMFT, plaque, and gingival index as compared to those with normal weight t significantly higher scores for DMFT, plaque, and gingival index as compared to those with normal weight (p<0.05)
12 months
the results of dmft, BEWE, ICDAS-II, probing dept
Time Frame: up to 12 months
No significant difference was observed concerning dmft and other factors (p>0.05)
up to 12 months
Comparison of demographic attributes between obese and normal weights
Time Frame: 12 months
Significant disparities were identified between patients with normal weight and those who were obese, particularly in BMI, income, and tooth brushing habits. Obese patients exhibited considerably higher BMI scores in comparison to those with normal weight (p<0.001).Body mass index (BMIs; kg/m2) was calculated by the pediatrician using the patients' height (meters) and weight (kilograms). BMI 5-85th percentile normal weight according to gender and age; BMI 85- 95 percentile overweight; Those at the 95th percentile and above were considered obese
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
biochemical parameters of obese individuals
Time Frame: 11 months
Procalcitonin exhibited significantly negative correlation between DMFT and ICDAS-II (p<0.05).
11 months
other biochemical parameters of obese individuals
Time Frame: up to 11 months
No significant correlation was found between the biomarkers and other investigated factors (p>0.05)
up to 11 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kahramanmaras Sutcu Imam University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2020

Primary Completion (Actual)

March 5, 2021

Study Completion (Actual)

April 29, 2021

Study Registration Dates

First Submitted

February 15, 2024

First Submitted That Met QC Criteria

February 22, 2024

First Posted (Estimated)

February 28, 2024

Study Record Updates

Last Update Posted (Estimated)

February 28, 2024

Last Update Submitted That Met QC Criteria

February 22, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2020/17

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pediatric Obesity

Clinical Trials on oral health status

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe